日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer.

化疗耐药肿瘤细胞分泌组增强了三阴性乳腺癌的免疫抑制作用

期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-025-02082-x
Skourti Eleni, Seip Kotryna, Mensali Nadia, Jabeen Shakila, Juell Siri, Øynebråten Inger, Pettersen Solveig, Engebraaten Olav, Corthay Alexandre, Inderberg Else Marit, Dolznig Helmut, Mælandsmo Gunhild Mari, Egeland Eivind Valen, Prasmickaite Lina
肿瘤
乳腺癌
发表日期：2025
文献求助 收藏

Spatial organization of the tumor-immune microenvironment in ER-positive breast cancer: remodeling during treatment and associations with clinical response

ER阳性乳腺癌肿瘤免疫微环境的空间组织：治疗期间的重塑及其与临床反应的关系

期刊:
影响因子:
doi:10.1101/2025.10.09.681336
Dahle, Maria Aanesland; Førde, Jan-Lukas; Egeland, Eivind Valen; Creason, Allison L; Watson, Cameron; Garred, Øystein; Prasmickaite, Lina; Mælandsmo, Gunhild M; Mills, Gordon B; Engebraaten, Olav; Haugen, Mads Haugland
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2025
文献求助 收藏

The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy

SRC家族是三阴性乳腺癌（对化疗产生耐药性）的治疗靶点。

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-024-02875-5
Egeland, Eivind Valen; Seip, Kotryna; Skourti, Eleni; Øy, Geir Frode; Pettersen, Solveig J; Pandya, Abhilash D; Dahle, Maria A; Haugen, Mads H; Kristian, Alexander; Nakken, Sigve; Engebraaten, Olav; Mælandsmo, Gunhild M; Prasmickaite, Lina
肿瘤
SRC
乳腺癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets

在类似干细胞的条件下培养癌细胞系，有可能揭示治疗靶点。

期刊:Experimental Cell Research
影响因子:3.5
doi:10.1016/j.yexcr.2008.03.008
Rappa, Germana; Mercapide, Javier; Anzanello, Fabio; Prasmickaite, Lina; Xi, Yaguang; Ju, Jingfang; Fodstad, Oystein; Lorico, Aurelio
肿瘤
肿瘤免疫
细胞生物学
干细胞
发育与干细胞
发表日期：2008
文献求助 收藏